Total Payments
$8,635
2024 Payments
$551.55
Companies
26
Transactions
282
Medicare Patients
3,069
Medicare Billing
$474,114
Payment Breakdown by Category
Food & Beverage$6,161 (71.3%)
Travel$1,539 (17.8%)
Research$928.80 (10.8%)
Education$6.25 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,161 | 271 | 71.3% |
| Travel and Lodging | $1,539 | 3 | 17.8% |
| Unspecified | $928.80 | 7 | 10.8% |
| Education | $6.25 | 1 | 0.1% |
Payments by Type
General
$7,706
275 transactions
Research
$928.80
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,685 | 8 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $1,083 | 64 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,022 | 38 | $0 (2024) |
| ViiV Healthcare Company | $928.80 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $592.99 | 31 | $0 (2024) |
| PFIZER INC. | $523.11 | 44 | $0 (2024) |
| Abbott Laboratories | $500.02 | 14 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $296.75 | 17 | $0 (2022) |
| Gilead Sciences, Inc. | $275.54 | 7 | $0 (2018) |
| Allergan, Inc. | $252.35 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $551.55 | 23 | AstraZeneca Pharmaceuticals LP ($295.21) |
| 2023 | $585.63 | 25 | AstraZeneca Pharmaceuticals LP ($310.21) |
| 2022 | $592.92 | 29 | AstraZeneca Pharmaceuticals LP ($287.48) |
| 2021 | $1,232 | 73 | Novartis Pharmaceuticals Corporation ($356.92) |
| 2020 | $226.28 | 13 | E.R. Squibb & Sons, L.L.C. ($80.67) |
| 2019 | $358.20 | 29 | E.R. Squibb & Sons, L.L.C. ($188.33) |
| 2018 | $2,131 | 44 | ViiV Healthcare Company ($928.80) |
| 2017 | $2,957 | 46 | Amgen Inc. ($1,643) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Infectious Diseases | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Infectious Diseases | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Rare Disease | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug), ANDEXXA, FARXIGA | Food and Beverage | In-kind items and services | $185.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Gastroenterology | ||||||
| 11/13/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY | ViiV Healthcare Company | $928.80 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,330 | 2,438 | $472,317 | $197,467 |
| 2022 | 13 | 949 | 2,060 | $344,993 | $168,886 |
| 2021 | 11 | 432 | 808 | $165,462 | $62,393 |
| 2020 | 6 | 358 | 547 | $188,205 | $45,368 |
Total Patients
3,069
Total Services
5,853
Medicare Billing
$474,114
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 305 | $85,919 | $27,067 | 31.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 111 | 460 | $80,500 | $25,835 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 151 | 163 | $43,940 | $20,796 | 47.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 67 | 148 | $29,600 | $17,152 | 57.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 91 | 175 | $31,500 | $14,089 | 44.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 51 | 169 | $24,924 | $13,208 | 53.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 214 | $34,806 | $12,774 | 36.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 86 | 95 | $23,750 | $12,717 | 53.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 45 | 104 | $22,064 | $11,326 | 51.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 157 | 179 | $21,968 | $10,185 | 46.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 80 | 81 | $24,036 | $6,858 | 28.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 40 | 116 | $12,412 | $6,355 | 51.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 73 | 84 | $10,584 | $5,206 | 49.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 34 | 36 | $9,362 | $4,832 | 51.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 41 | 42 | $7,432 | $4,214 | 56.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 35 | 37 | $5,920 | $3,657 | 61.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 30 | 30 | $3,600 | $1,194 | 33.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 199 | 786 | $130,737 | $62,142 | 47.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 47 | 164 | $32,152 | $16,982 | 52.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 99 | 109 | $32,403 | $16,351 | 50.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 54 | 213 | $29,940 | $14,946 | 49.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 82 | 244 | $29,401 | $13,505 | 45.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 109 | 118 | $19,503 | $9,457 | 48.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 65 | 72 | $17,520 | $9,181 | 52.4% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 75 | 80 | $13,005 | $6,828 | 52.5% |
About Dr. Jose Burgos, M.D
Dr. Jose Burgos, M.D is a Hospice and Palliative Medicine healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245437425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Burgos, M.D has received a total of $8,635 in payments from pharmaceutical and medical device companies, with $551.55 received in 2024. These payments were reported across 282 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($6,161).
As a Medicare-enrolled provider, Burgos has provided services to 3,069 Medicare beneficiaries, totaling 5,853 services with total Medicare billing of $474,114. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Internal Medicine
- Location El Paso, TX
- Active Since 06/29/2007
- Last Updated 11/13/2024
- Taxonomy Code 207RH0002X
- Entity Type Individual
- NPI Number 1245437425
Products in Payments
- ELIQUIS (Drug) $1,355
- BRILINTA (Drug) $712.98
- ENTRESTO (Drug) $592.99
- XARELTO (Drug) $296.75
- LOKELMA (Drug) $277.37
- UTIBRON (Drug) $240.12
- Epclusa (Drug) $237.01
- CHANTIX (Drug) $208.03
- XIFAXAN (Drug) $203.33
- AVYCAZ (Drug) $161.43
- Orbactiv (Drug) $124.99
- TEFLARO (Drug) $122.20
- Baxdela (Drug) $120.00
- Veltassa (Drug) $117.59
- ICDs (Device) $111.95
- SOLIRIS (Drug) $109.01
- Xultophy 100/3.6 (Drug) $100.04
- Victoza (Drug) $97.71
- Cresemba (Drug) $75.30
- Unify Assura CRT Defibrillator (Device) $63.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in El Paso
Juan Becerra, M.d, M.D
Hospice and Palliative Medicine — Payments: $8,368
Hospice and Palliative Medicine $8,368
Dr. Mathews George, Md, MD
Hospice and Palliative Medicine — Payments: $5,013
Hospice and Palliative Medicine $5,013
Bhaskar Rao, Md, MD
Hospice and Palliative Medicine — Payments: $864.23
Hospice and Palliative Medicine $864.23